In a partial victory for Ranbaxy Laboratories in its patent litigation against Pfizer ,an Australian court has ruled in the Indian company's favour in a case relating to cholesterol lowering drug atorvastatin(Lipitor).The court at the same also ruled that a proposed Ranbaxy generic product under a different patent infringed Pfizer's basic Lipitor patent (number 601981)
Ranbaxy's senior vice president (global intellectual property) Jay Deshmukh said "We are pleased with this decision as it advances the entry of ranbaxy's generic atorvastatin in Australia to May 18,2012"
Subscribe to:
Post Comments (Atom)
1 comment:
Lipitor is a great generic medicine like Kamagra Viagra and I hope the ranbaxy don't interrupts the production of this medicine.
Post a Comment